Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.
To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Platelet activating factor
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).
Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).
Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Mathison R et al. | Regulation of leukocyte adhesion to heart by the tripeptides feG and feG(NH2). | 2001 | Can. J. Physiol. Pharmacol. | pmid:11599779 |
Havt A et al. | The renal effects of Bothrops jararacussu venom and the role of PLA(2) and PAF blockers. | 2001 | Toxicon | pmid:11600146 |
Yu P et al. | [Pathogenetic effect of platelet activating factor on enterogenic endotoxemia after burn]. | 1999 | Zhonghua Yi Xue Za Zhi | pmid:11601022 |
Tsai MH et al. | Effect of platelet activating factor and butyrate on the expression of interleukin-2 receptor alpha in nasopharyngeal carcinoma cells. | 2001 | Int. J. Oncol. | pmid:11605008 |
Fabi F et al. | Nitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathways. | 2001 | Br. J. Pharmacol. | pmid:11606318 |
Berdyshev EV et al. | Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. | 2001 | FASEB J. | pmid:11641243 |
Storey RF et al. | Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood. | 2001 | Platelets | pmid:11674863 |
Camici M and Sagripanti A | Plasma platelet activating factor in nephrotic syndrome. | 2001 | Minerva Med. | pmid:11675576 |
Kohno S and Nabe T | [Inflammatory mediators (leukotrienes, thromboxane A2, tachykinins and others)]. | 2001 | Nippon Rinsho | pmid:11676130 |
Pettorossi VE and Grassi S | Different contributions of platelet-activating factor and nitric oxide in long-term potentiation of the rat medial vestibular nuclei. | 2001 | Acta Otolaryngol Suppl | pmid:11677732 |
Wielockx B et al. | Involvement of a serine protease, but not of neutrophil elastase, in tumor necrosis factor-induced lethal hepatitis and induction of platelet-activating factor. | 2001 | J. Hepatol. | pmid:11682033 |
Dutra PM et al. | Platelet-activating factor modulates a secreted phosphatase activity of the trypanosomatid parasite Herpetomonas muscarum muscarum. | 2001 | Curr. Microbiol. | pmid:11683365 |
Marathe GK et al. | Oxidized LDL contains inflammatory PAF-like phospholipids. | 2001 Apr-May | Trends Cardiovasc. Med. | pmid:11686003 |
den Dekker E et al. | Biogenesis of G-protein mediated calcium signaling in human megakaryocytes. | 2001 | Thromb. Haemost. | pmid:11686331 |
Kaul DK et al. | Ameliorating effects of fluorocarbon emulsion on sickle red blood cell-induced obstruction in an ex vivo vasculature. | 2001 | Blood | pmid:11698300 |
Casao MA et al. | Promotion of platelet aggregation by sera from brucellosis patients with antiphosphatidylcholine antibodies. | 2001 | J. Med. Microbiol. | pmid:11699593 |
Lendvai B et al. | Platelet-activating factor evokes Ca2+ transients after the blockade of ryanodine receptor by dantrolene in RAW 264.7 macrophages. | 2001 | Neurochem. Res. | pmid:11699928 |
Houghton TJ et al. | Efficient assembly of the phomactin core via two different macrocyclization protocols. | 2001 | Org. Lett. | pmid:11700095 |
Adams JM et al. | Entry of gut lymph into the circulation primes rat neutrophil respiratory burst in hemorrhagic shock. | 2001 | Crit. Care Med. | pmid:11700422 |
Masuhara K et al. | Involvement of platelet activation in experimental osteonecrosis in rabbits. | 2001 | Int J Exp Pathol | pmid:11703540 |
Bernatchez PN et al. | Regulation of VEGF-induced endothelial cell PAF synthesis: role of p42/44 MAPK, p38 MAPK and PI3K pathways. | 2001 | Br. J. Pharmacol. | pmid:11704645 |
Ibe BO et al. | Maturational changes in ovine pulmonary metabolism of platelet-activating factor: implications for postnatal adaptation. | 2001 | Mol. Genet. Metab. | pmid:11708870 |
Suwaki T et al. | Modification of eosinophil function by suplatast tosilate (IPD), a novel anti-allergic drug. | 2001 | Int. Immunopharmacol. | pmid:11710545 |
Macphee CH | Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target. | 2001 | Curr Opin Pharmacol | pmid:11714085 |
Claman P | Platelet activating factor does not improve intrauterine insemination outcome. | 2001 | Am. J. Obstet. Gynecol. | pmid:11717679 |
Logan JE and Roudebush WE | Platelet-activating factor increases intracellular calcium levels in preimplantation stage embryos. | 2000 | Early Pregnancy | pmid:11719820 |
Caplan MS and Jilling T | The role of polyunsaturated fatty acid supplementation in intestinal inflammation and neonatal necrotizing enterocolitis. | 2001 | Lipids | pmid:11724457 |
de Meis L | Role of the sarcoplasmic reticulum Ca2+-ATPase on heat production and thermogenesis. | 2001 | Biosci. Rep. | pmid:11725862 |
McHowat J et al. | Endothelial cell PAF synthesis following thrombin stimulation utilizes Ca(2+)-independent phospholipase A(2). | 2001 | Biochemistry | pmid:11732912 |
Binisti C et al. | Structure-activity relationships in platelet-activating factor (PAF). 11-From PAF-antagonism to phospholipase A(2) inhibition: syntheses and structure-activity relationships in 1-arylsulfamido-2-alkylpiperazines. | 2001 | Eur J Med Chem | pmid:11738488 |
Stangl V et al. | Negative inotropic mediators released from the heart after myocardial ischaemia-reperfusion. | 2002 | Cardiovasc. Res. | pmid:11744010 |
Haynes J and Obiako B | Activated polymorphonuclear cells increase sickle red blood cell retention in lung: role of phospholipids. | 2002 | Am. J. Physiol. Heart Circ. Physiol. | pmid:11748055 |
Uhlmann D et al. | Importance of microcirculatory disturbances in the pathogenesis of pancreatitis. | 2001 | Zentralbl Chir | pmid:11753796 |
Rivera A et al. | Modulation of Gardos channel activity by cytokines in sickle erythrocytes. | 2002 | Blood | pmid:11756192 |
Closa D et al. | Absorption and effects of 3-(N-phenylamino)-1,2-propanediol esters in relation to toxic oil syndrome. | 2001 | Lipids | pmid:11768157 |
Añel RL and Kumar A | Experimental and emerging therapies for sepsis and septic shock. | 2001 | Expert Opin Investig Drugs | pmid:11772263 |
Zhu W et al. | Effects of platelet activating factor antagonist (BN50739) on gut mucosal injury in acute severe pancreatitis in pigs. | 2000 | Chin. Med. J. | pmid:11776064 |
Ichinowatari G et al. | Participation of prostaglandin E2 and platelet-activating factor in thapsigargin-induced production of interleukin-6. | 2002 | Eur. J. Pharmacol. | pmid:11779582 |
Hanada K et al. | Plasmodium falciparum phospholipase C hydrolyzing sphingomyelin and lysocholinephospholipids is a possible target for malaria chemotherapy. | 2002 | J. Exp. Med. | pmid:11781362 |
Hiran T et al. | Evidence for the involvement of the NADPH oxidase enzyme complex in the optimal accumulation of Platelet-activating factor in the human cell line PLB-985. | 2001 | Prostaglandins Other Lipid Mediat. | pmid:11785782 |
Ohshima N et al. | Receptor-dependent metabolism of platelet-activating factor in murine macrophages. | 2002 | J. Biol. Chem. | pmid:11786559 |
Nagase T et al. | Airway hyperresponsiveness in transgenic mice overexpressing platelet activating factor receptor is mediated by an atropine-sensitive pathway. | 2002 | Am. J. Respir. Crit. Care Med. | pmid:11790655 |
Roudebush WE et al. | Relationship between platelet-activating factor concentration in rhesus monkey (Macaca mulatta) spermatozoa and sperm motility. | 2002 | Am. J. Primatol. | pmid:11793409 |
Shah BH et al. | Molecular mechanisms involved in human platelet aggregation by synergistic interaction of platelet-activating factor and 5-hydroxytryptamine. | 2001 | Exp. Mol. Med. | pmid:11795484 |
Cheminade C et al. | 1-O-alkylglycerols improve boar sperm motility and fertility. | 2002 | Biol. Reprod. | pmid:11804958 |
Walterscheid JP et al. | Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. | 2002 | J. Exp. Med. | pmid:11805144 |
Ribeiro JM and Francischetti IM | Platelet-activating-factor-hydrolyzing phospholipase C in the salivary glands and saliva of the mosquito Culex quinquefasciatus. | 2001 | J. Exp. Biol. | pmid:11807106 |
Unno N et al. | Association of a G994 -->T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with risk of abdominal aortic aneurysm in Japanese. | 2002 | Ann. Surg. | pmid:11807372 |
Johansson S et al. | A neutrophil multitarget functional bioassay to detect anti-inflammatory natural products. | 2002 | J. Nat. Prod. | pmid:11809061 |
Drost EM and MacNee W | Potential role of IL-8, platelet-activating factor and TNF-alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis. | 2002 | Eur. J. Immunol. | pmid:11813158 |